Reference health

Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment

https://doi.org/10.1016/j.jddst.2020.101634
CiteStamped reference-health badge
31/31 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

7 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 31 checked references that resolve
resolves10.1016/j.ijpharm.2016.10.006
Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment
resolves10.1016/j.drudis.2016.03.013
Bilosomes in the context of oral immunization: development, challenges and opportunities
resolves10.1016/S0264-410X(00)00537-5
Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)
resolves10.3109/1061186X.2012.747528
Characterization and optimization of bilosomes for oral vaccine delivery
resolves10.3389/fphar.2018.01283
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
resolves10.1016/j.ejpb.2012.02.009
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: The effect of cholate type, particle size and administered dose
resolves10.1016/j.apsb.2011.09.002
Nonionic surfactant vesicular systems for effective drug delivery—an overview
resolves10.1016/S0378-5173(98)00169-0
Non-ionic surfactant based vesicles (niosomes) in drug delivery
resolves10.1208/s12249-010-9480-2
Formulation and Optimization of Zidovudine Niosomes
resolves10.2174/1381612823666170124111142
Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides
resolves10.1023/A:1011981317451
Linear Correlation of the Fraction of Oral Dose Absorbed of 64 Drugs Between Humans and Rats
resolves10.1016/j.colsurfb.2018.10.041
Different BRIJ97 colloid systems as potential enhancers of acyclovir skin permeation and depot
resolves10.1016/j.ijpharm.2018.09.053
Soluplus micelles for acyclovir ocular delivery: Formulation and cornea and sclera permeability
resolves10.4103/0975-1483.90236
Formulation and Optimization of Mucoadhesive Nanodrug Delivery System of Acyclovir
resolves10.1016/j.ijpharm.2017.07.024
Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir
resolves10.1016/j.ijpharm.2009.05.025
Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability
resolves10.1016/j.ejps.2018.06.005
Semisolid self-microemulsifying drug delivery systems (SMEDDSs): Effects on pharmacokinetics of acyclovir in rats
resolves10.1211/jpp.58.6.0002
Particulate delivery systems for vaccines: what can we expect?
resolves10.1016/j.ijpharm.2015.03.033
Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam
resolves10.1080/03639045.2017.1361968
Improved hepatoprotective activity of silymarin via encapsulation in the novel vesicular nanosystem bilosomes
resolves10.1080/1061186X.2016.1191080
Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers
resolves10.1080/03639040701385527
Oral Bioavailability Enhancement of Acyclovir by Self-Microemulsifying Drug Delivery Systems (SMEDDS)
resolves10.1080/10717544.2017.1337823
Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
resolves10.1016/j.jhazmat.2007.05.061
Statistical optimization of medium components and growth conditions by response surface methodology to enhance phenol degradation by Pseudomonas putida
resolves10.1080/02652040802055411
Vesicular aceclofenac systems: A comparative study between liposomes and niosomes
resolves10.1016/j.ijpharm.2009.04.022
Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt
resolves10.3109/10717541003667764
Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: Development, characterization, and in vivo evaluation
resolves10.1016/j.nano.2013.08.012
Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration
resolves10.3109/03639045.2013.801984
Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants:<i>ex vivo, in situ</i>and<i>in vivo</i>studies
resolves10.2147/IJN.S83123
Optimization, ex vivo permeation, and stability study of lipid nanocarrier loaded gelatin capsules for treatment of intermittent claudication
resolves10.2147/IJN.S82558
Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine
The 7 references without a DOI — listed, not checked
no DOI — not checkedBile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines
no DOI — not checkedAcyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy
no DOI — not checkedFormulation and evaluation of acyclovir nanosuspension for enhancement of oral bioavailability
no DOI — not checkedDevelopment and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments
no DOI — not checkedPharmaceutical manufacturing of liposomes
no DOI — not checkedA review of in vitro drug release test methods for nano-sized dosage forms
no DOI — not checkedRole of novel drug delivery systems in bioavailability enhancement at a glance
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.jddst.2020.101634"><img src="https://citestamp.com/citestamped/10.1016/j.jddst.2020.101634/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.jddst.2020.101634/badge.svg)](https://citestamp.com/citestamped/10.1016/j.jddst.2020.101634)